Sputnik-V: Interim Trials Show Promising Results
The Russian "Sputnik-V" vaccine has shown more than 90 percent effectiveness in the ongoing interim trials. According to a study by Lancet journal, Sputnik-V is effective against many variants of Covid-19. Hildegund C.J. Ertl, a vaccine scientist at Wistar Institute said that the "results are great". He also said that the Russian vaccine has proven to be one of the safest and effective vaccines in the world.